Determinants of in vitro drug susceptibility testing of Plasmodium vivax.

Determinants of in vitro drug susceptibility testing of Plasmodium vivax.

In Papua, Indonesia, the antimalarial susceptibility of Plasmodium vivax (n = 216) and P. falciparum (n = 277) was assessed using a modified schizont maturation assay for chloroquine, amodiaquine, artesunate, lumefantrine, mefloquine, and piperaquine. The most effective antimalarial against P. vivax...

Full description

Bibliographic Details
Main Authors:	Russell, B, Chalfein, F, Prasetyorini, B, Kenangalem, E, Piera, K, Suwanarusk, R, Brockman, A, Prayoga, P, Sugiarto, P, Cheng, Q, Tjitra, E, Anstey, N, Price, R
Format:	Journal article
Language:	English
Published:	2008

Similar Items

In vitro and molecular characterisation of multidrug resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
by: Price, R, et al.
Published: (2010)

Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms.
by: Suwanarusk, R, et al.
Published: (2007)

Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.
by: Suwanarusk, R, et al.
Published: (2008)

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2011)

In vivo and in vitro efficacy of chloroquine against Plasmodium malariae and P. ovale in Papua, Indonesia.
by: Siswantoro, H, et al.
Published: (2011)

In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquine-resistant Plasmodium vivax.
by: Hasugian, A, et al.
Published: (2009)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
by: Lampah, D, et al.
Published: (2011)

Plasmodium vivax susceptibility to ferroquine.
by: Leimanis, M, et al.
Published: (2010)

Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
by: Marfurt, J, et al.
Published: (2012)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
by: Price, R, et al.
Published: (2007)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria.
by: Salwati, E, et al.
Published: (2011)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Quantification of Plasmodium ex vivo drug susceptibility by flow cytometry.
by: Wirjanata, G, et al.
Published: (2015)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
by: Karyana, M, et al.
Published: (2008)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses.
by: Woodberry, T, et al.
Published: (2008)

Potent ex vivo activity of naphthoquine and methylene blue against drug-resistant clinical isolates of Plasmodium falciparum and Plasmodium vivax
by: Wirjanata, G, et al.
Published: (2015)

Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia
by: Marfurt, J, et al.
Published: (2021)

High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions.
by: Handayani, S, et al.
Published: (2009)

Comparison of three molecular methods for the detection and speciation of Plasmodium vivax and Plasmodium falciparum.
by: Boonma, P, et al.
Published: (2007)

Gametocyte dynamics and the role of drugs in reducing the transmission potential of Plasmodium vivax.
by: Douglas, N, et al.
Published: (2013)

Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine-pyrimethamine in southern Papua, Indonesia.
by: Ratcliff, A, et al.
Published: (2007)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
by: Kho, S, et al.
Published: (2018)

Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
by: Wirjanata, G, et al.
Published: (2015)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, E, et al.
Published: (2017)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
by: Thriemer, K, et al.
Published: (2020)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
by: Setyadi, A, et al.
Published: (2019)

Dihydroartemisinin-piperaquine versus artesunate-amodiaquine: superior efficacy and posttreatment prophylaxis against multidrug-resistant Plasmodium falciparum and Plasmodium vivax malaria.
by: Hasugian, A, et al.
Published: (2007)

Vivax malaria: a major cause of morbidity in early infancy.
by: Poespoprodjo, JR, et al.
Published: (2009)

Alternative treatment options for chloroquine resistant Plasmodium vivax in Papua, Indonesia
by: Price, R, et al.
Published: (2005)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
by: Douglas, N, et al.
Published: (2014)

Plasmodium vivax trophozoites insensitive to chloroquine.
by: Sharrock, W, et al.
Published: (2008)

The anaemia of Plasmodium vivax malaria.
by: Douglas, N, et al.
Published: (2012)